# US 2020/0368710 A1 · Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0368710 A1
- Document ID: US20200368710A1
- Status: Published application
- Kind: A1
- Application number: 16/988,827
- Filed: 2020-08-10
- Published: 2020-11-26
- Earliest claimed: 2014-08-15
- Assignees: Massachusetts Institute of Technology
- Applicants: Massachusetts Institute of Technology
- Inventors: Klavs F. Jensen; Timothy F. Jamison; Allan S. Myerson; Jean-Christophe M. Monbaliu; Mohsen Behnam; Shin Yee Wong; Nopphon Weeranoppanant; Eve Marie Revalor; Torsten Stelzer; Jie Chen; Andrea Adamo; David R. Snead; Ping Zhang
- Web page: https://patentgrep.com/patent/US20200368710A1

## CPC

- B01J 19/004: {Multifunctional apparatus for automatic manufacturing of various chemical products (sequential reactions B01J19/0046)}
- B01J 19/0093: {Microreactors, e.g. miniaturised or microfabricated reactors (laboratory containers with capillary fluid transport in microfabricated channels or chambers B01L3/5027)}
- A61K 31/14: Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205)
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- B01J 2219/00011: Laboratory-scale plants
- B01J 2219/0002: Plants assembled from modules joined together
- B01J 2219/0004: Processes in series
- B01J 2219/00795: Spiral-shaped
- B01J 2219/00799: Cup-shaped
- B01J 2219/00806: Frames
- B01J 2219/0081: Plurality of modules
- B01J 2219/00813: Fluidic connections
- B01J 2219/00817: Support structures
- B01J 2219/00822: Metal
- B01J 2219/00831: Glass
- B01J 2219/00833: Plastic
- B01J 2219/00835: Comprising catalytically active material
- B01J 2219/00871: Modular assembly
- B01J 2219/00873: Heat exchange
- B01J 2219/00889: Mixing
- B01J 2219/00907: using membranes
- B01J 2219/00909: using filters
- B01J 2219/00918: by adsorption
- B01J 2219/00986: Microprocessor
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients, are provided. Certain of the systems and methods described herein are capable of manufacturing multiple chemical products without the need to fluidically connect or disconnect unit operations when switching from one making chemical product to making another chemical product.

## Claims

### Claim at position 1

1-29. (canceled)

### Claim 30

A method for producing chemical products, comprising:
transporting a first fluid comprising a first chemical reactant through a first module comprising a chemical reactor and at least a second unit operation fluidically connected in parallel, and through a second module connected to the first module in series, the second module comprising at least one separator and at least a fourth unit operation fluidically connected in parallel, such that the first chemical reactant within the first fluid is reacted to form a first chemical product that is transported out of the second module; and
subsequently, transporting a second fluid comprising a second chemical reactant through the first module and the second module such that the second chemical reactant within the second fluid is reacted to form a second chemical product, without forming the first chemical product, such that the second chemical product is transported out of the second module;
wherein:
no additional unit operations are newly fluidically connected to the first and second modules between the steps of transporting the first fluid and transporting the second fluid, and
no unit operations are fluidically disconnected from the first and second modules between the steps of transporting the first fluid and transporting the second fluid.

### Claim 31 (depends on 30)

The method of claim 30, wherein transporting the first fluid through the separator comprises separating the first fluid into a first stream containing the first chemical product and a second stream containing a first chemical byproduct.

### Claim 32 (depends on 30)

The method of claim 30, wherein the first and/or second chemical products is an active pharmaceutical ingredient (API).

### Claim 33 (depends on 32)

The method of claim 32, wherein the API is diphenhydramine, lidocaine, diazepam, and/or fluoxetine.

### Claim 34 (depends on 32)

The method of claim 32, wherein the API is processed downstream into a tablet, a pill, or a liquid.

### Claim 35 (depends on 30)

The method of claim 30, wherein the first and/or second chemical product contains at least about 2.5 mg of the API per milliliter suspended in a pharmaceutically acceptable carrier.

### Claim at position 8

36-37. (canceled)

### Claim 38 (depends on 30)

The method of claim 30, wherein the reactor has a volume of less than or equal to about 1 L.

### Claim at position 10

39-41. (canceled)

### Claim 42 (depends on 30)

The method of claim 30, wherein the at least one reactor is operated at a pressure of greater than or equal to about 200 psi.

### Claim 43 (depends on 30)

The method of claim 30, wherein the at least one reactor is operated at a temperature of greater than or equal to about 60° C.

### Claim at position 13

44-45. (canceled)

### Claim 46

A method for the continuous production of an ingestible pharmaceutical composition within a reactor system, comprising:
transporting an input fluid comprising a chemical reactant through a reactor such that the chemical reactant is reacted, within the reactor, to produce an active pharmaceutical ingredient within a reactor output stream;
transporting the reactor output stream to a separator and separating at least a portion of the active pharmaceutical ingredient from at least a portion of another component of the reactor output stream to produce a separator product stream having a higher concentration of the active pharmaceutical ingredient than the reactor output stream; and
transporting the separator product stream from the separator to a formulator in which the active pharmaceutical ingredient is converted into the ingestible pharmaceutical composition,
wherein the amount of the active pharmaceutical ingredient within the ingestible pharmaceutical composition that is output from the formulator is output at a rate of at least about 20 grams/day, and
wherein the reactor system, including the reactor, the separator, and the formulator, are contained within a housing occupying a volume of less than about 100 ft3 and/or occupying a footprint of less than about 10 ft2.

### Claim 47 (depends on 46)

The method of claim 46, wherein the housing occupies a footprint of less than about 10 ft2.

### Claim 48 (depends on 46)

The method of claim 46, wherein the housing occupies a volume of less than about 100 ft3.

### Claim at position 17

49-50. (canceled)

### Claim 51 (depends on 46)

The method of claim 46, wherein the active pharmaceutical ingredient is diphenhydramine, lidocaine, diazepam, and/or fluoxetine.

### Claim 52 (depends on 46)

The method of claim 46, wherein the ingestible pharmaceutical composition is a tablet, a pill, or a liquid.

### Claim 53 (depends on 46)

The method of claim 46, wherein the reactor has a volume of less than or equal to about 1 L.

### Claim at position 21

54-56. (canceled)

### Claim 57 (depends on 46)

The method of claim 46, wherein the reactor is operated at a pressure of greater than or equal to about 200 psi.

### Claim 58 (depends on 46)

The method of claim 46, wherein the reactor is operated at a temperature of greater than or equal to about 60° C.

### Claim at position 24

59-60. (canceled)

### Claim 61 (depends on 46)

The method of claim 46, wherein the separator product stream is transported from the separator to a formulator comprising a precipitator, a filter, a dissolution tank, and/or an additional formulation unit.

### Claim 62

(canceled)

### Claim 63 (depends on 46)

The method of claim 46, wherein converting the active pharmaceutical ingredient into the ingestible pharmaceutical composition comprises:
precipitating the active pharmaceutical ingredient from a solution comprising the active pharmaceutical ingredient and a pharmaceutically acceptable solvent, and/or
crystallizing the active pharmaceutical ingredient from a solution comprising the active pharmaceutical ingredient and a pharmaceutically acceptable solvent, and/or
diluting the active pharmaceutical ingredient with a pharmaceutically acceptable solvent.

### Claim at position 28

64-66. (canceled)

### Claim 67 (depends on 46)

The method of claim 46, wherein the reactor output stream and/or separator product stream is transported without a pump.
